A Gaitherburg biotech is raising millions to treat nicotine-related diseases — and help smokers quit

Favicon The Washington Business Journal

The clinical-stage company is developing a drug that would diminish the effects of nicotine in the body.

Read the full article here: The Washington Business Journal


The post: «A Gaitherburg biotech is raising millions to treat nicotine-related diseases — and help smokers quit» has been published on the website The Washington Business Journal where, everyday, you can find the latest news about Washington's area.



Get more articles about this topic

Leave a comment